Cambridge based company Mogrify plan to use big data to discover, optimise and commercialise transdifferentiations- generating cells from adult cells without reverting them to a pluripotent state.
But will they be able to play catch up with stem cell therapies have already made it to clinical trials?
-----------------
Follow me on
LinkedIn: http://tiny.cc/hoggbz
Facebook: http://tiny.cc/diggbz
Twitter: http://tiny.cc/6iggbz
Instagram: http://tiny.cc/bkggbz
Content by Maaria Ginai (C) 2019
